The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer-Reference-Cited by-同舟云学术

The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer

Published:2016-10-20 Issue:46 Volume:7 Page:75518-75525
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Toomey Sinead¹,Madden Stephen F.²,Furney Simon J.³,Fan Yue⁴,McCormack Mark⁵,Stapleton Carragh⁵,Cremona Mattia¹,Cavalleri Gianpiero L.⁵,Milewska Malgorzata¹,Elster Naomi¹,Carr Aoife¹,Fay Joanna⁶,Kay Elaine W.⁶,Kennedy Susan⁷,Crown John⁷,Gallagher William M.⁴,Hennessy Bryan T.¹⁸,Eustace Alex J.¹

Affiliation:

1. Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Ireland

2. Population Health Sciences Division, Royal College of Surgeons in Ireland, Ireland

3. School of Medicine, University College Dublin, Ireland

4. University College Dublin, UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, Ireland

5. Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Ireland

6. Department of Histopathology, Beaumont Hospital, Dublin, Ireland

7. St Vincent's University Hospital, Dublin, Ireland

8. Department of Oncology, Beaumont Hospital, Dublin, Ireland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk and Resilience Variants in the Retinoic Acid Metabolic and Developmental Pathways Associated with Risk of FASD Outcomes;Biomolecules;2024-05-10

2. A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast Cancer;Mini-Reviews in Medicinal Chemistry;2023-06

3. Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review;Cancer Drug Resistance;2022

4. SNPs Ability to Influence Disease Risk: Breaking the Silence on Synonymous Mutations in Cancer;Single Nucleotide Polymorphisms;2022

5. Target therapy in cancer treatment;Nuclear Medicine and Molecular Imaging;2022